Advertisement

Krankheitsrisiko und Nutzen der Therapie bei milder Hypertonie

  • M. Anlauf
  • F. Weber
Conference paper

Zusammenfassung

In der Bevölkerung (zwischen 30 bis 70 Jahren) sind rund 23% der Männer und 12% der Frauen von einer milden (besser »leichten«) Hypertonie (28, 29) betroffen (18), unter den Hypertonikern sind es 75 bis 85%. Der diastolische Blutdruck dieser Patienten ist definitionsgemäß auf 90–104 mmHg erhöht.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zu den besprochenen Studien

  1. 1.
    Management Commitee (1980) The Australian Therapeutic Trial in Mild Hypertension. Lancet I:1261–1267Google Scholar
  2. 2.
    Management Commitee of the Australian Therapeutic Trial in Mild Hypertension (1982) Untreated mild Hypertension. Lancet II:185–191Google Scholar
  3. 3.
    Management Commitee (1984) Prognostic factors in the treatment of mild hypertension. Circulation 69:668–676CrossRefGoogle Scholar
  4. 4.
    HDFP Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-Year Findings of the Hypertension Detection and Follow-up Program. I. Reduction in Mortality of Persons With High Blood Pressure, Including Mild Hypertension. JAMA 242:2562–2571CrossRefGoogle Scholar
  5. 5.
    HDFP Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-Year Findings of the Hypertension Detection and Follow-up Program. II. Mortality by Race, Sex and Age. JAMA 242:2572–2577CrossRefGoogle Scholar
  6. 6.
    HDFP Hypertension Detection and Follow-up Program Cooperative Group (1982) Five-year Findings of the Hypertension Detection and Follow-up Program. III. Reduction in Stroke Incidence among Persons with High Blood Pressure. JAMA 247:633–638Google Scholar
  7. 7.
    HDFP Hypertension Detection and Follow-up Program Cooperative Group (1982) The Effect of Treatment on Mortality in “Mild” Hypertension. N Engl J Med 307:976–980CrossRefGoogle Scholar
  8. 8.
    Helgeland A (1980) Treatment of Mild Hypertension: A Five Year Controlled Drug Trial. The Oslo Study. Am J Med 69:725–732PubMedCrossRefGoogle Scholar
  9. 9.
    Medical Research Council Working Party (1977) Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Br Med J I:1437–1440Google Scholar
  10. 10.
    Medical Research Council Working Party (1985) MRC trial of treatment of mild hypertension: principal results. Brit Med J 291:97–104CrossRefGoogle Scholar

Weitere Literatur

  1. 11.
    Amery A, Birkenhäger W, Brixko P, Bulpitt C et al. (1985) Mortality And Morbidity Results From The European Working Party On High Blood Pressure In The Elderly Trial, Lancet I:1349–1354CrossRefGoogle Scholar
  2. 12.
    Anlauf M, Weber F, Bock KD (1986) Milde Hypertonie: Risiko und Chance: Ergebnisse kontrollierter Studien. Münch Med Wochenschr 128:81–86Google Scholar
  3. 13.
    Bulpitt CJ (1983) Randomised controlled clinical trials. Martin us Nijhoff Publishers, The Hague, Boston, LondonGoogle Scholar
  4. 14.
    Epstein FH (1979) An Epidemiological View of Mild Hypertension. In: Gross F, Strasser T (eds) Mild Hypertension: Natural History and Management, Pitman Medical Publishing, KentGoogle Scholar
  5. 15.
    Füller A, Keil U, Nissinen A, Laaser U (1981) Epidemiologie des Hochdruckrisikos. Münch Med Wochenschr 123:1775–1779Google Scholar
  6. 16.
    Holzgreve H (1981) Die Prognose der arteriellen Hypertonie und ihre Beeinflussung durch antihypertensive Therapie. Internist 22:156–161PubMedGoogle Scholar
  7. 17.
    The IPPPSH Collaborative Group (1985) Cardiovascular risk and risk factors in a randomised trial of treatment based on the beta-blocker oxprenolol, the international prospective primary prevention study in hypertension (IPPPSH). Hypertension 3:379–392CrossRefGoogle Scholar
  8. 18.
    Keil U, Döring A, Stieber J (1983) Community Studies in the Federal Republic of Germany. In: Gross F, Strasser T (eds) Mild Hypertension: Recent advances. Raven Press, New YorkGoogle Scholar
  9. 19.
    Multiple risk factor intervention trial research group (1982) Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 248:1465–1477CrossRefGoogle Scholar
  10. 20.
    Sleight P (1984) The choice of drug therapy in hypertension. In: Sobel BE, Julian DG, Hugenholtz PG (eds) Perspectives in cardiology. LondonGoogle Scholar
  11. 21.
    Steinbach M, Constantineanu M, Georgescu M, Harnagea P, Theodorini S, Galfi L, Damsa T, Schioiu L, Mitu S, Popescu AL, Cucu F, Ionescu A (1984) The Bucharest multifactorial prevention trial of coronary heart disease — ten year follow-up: 1971–1982. Rev Rourn Med - Med Int 22:99–106Google Scholar
  12. 22.
    Toth PJ, Horwitz RI (1983) Conflicting clinical trials and the uncertainty of treating mild hypertension. Am J Med 75:482–488PubMedCrossRefGoogle Scholar
  13. 23.
    United States Public Health Service Hospitals Cooperative Study Group (1972) Morbidity and mortality in mild essential hypertension. Circulation Research, Suppl II, 30 and 31:101–121Google Scholar
  14. 24.
    United States Public Health Service Hospitals Cooperative Study Group Mc Fate-Smith W (1977) Treatment of mild hypertension. Circ Res, Suppl I, 40:98–105Google Scholar
  15. 25.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II. Results in Patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 213:1143–1152CrossRefGoogle Scholar
  16. 26.
    Veterans Administration — National Heart, Lung, and Blood Institute Study Group for Cooperative Studies on Antihypertensive Therapy (1977) Mild Hypertension. In: Perry HM Jr (ed) Treatment of mild hypertension. Circ Res 40 [Suppl I] :180–187Google Scholar
  17. 27.
    WHO/ISH Mild Hypertension Liaison Committee (1982) Trials of the treatment of mild hypertension. Lancet 1:149–156Google Scholar
  18. 28.
    Memorandum from a WHO/ISH Meeting (1983) Guidelines for the treatment of mild hypertension. Hypertension 5:394–397Google Scholar
  19. 29.
    Memorandum from a WHO/ISH Meeting: 1986 guidelines for the treatment of mild hypertension (i. press)Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1986

Authors and Affiliations

  • M. Anlauf
    • 1
  • F. Weber
  1. 1.Medizinische Klinik und Poliklinik der Universität EssenEssen 1Deutschland

Personalised recommendations